TY - JOUR
T1 - Prevalence of Underlying Medical Conditions Associated with Severe COVID-19 Illness in Adult Cancer Survivors in the United States
AU - Jiang, Changchuan
AU - Yabroff, K. Robin
AU - Deng, Lei
AU - Perimbeti, Stuthi
AU - Han, Xuesong
N1 - Publisher Copyright:
© 2021 The Author(s) 2021. Published by Oxford University Press. All rights reserved. For permissions, please email: [email protected].
PY - 2022/1/1
Y1 - 2022/1/1
N2 - Cancer, and other underlying medical conditions including chronic obstructive pulmonary disease, heart diseases, diabetes, chronic kidney disease, and obesity, are associated with increased risk of severe coronavirus disease 2019 (COVID-19) illness. We identified 6411 cancer survivors and 77 748 adults without a cancer history from the 2016-2018 National Health Interview Survey and examined the prevalence and sociodemographic factors associated with these conditions in the United States. Most survivors reported having 1 or more of the conditions (56.4%, 95% confidence interval [CI] = 54.8% to 57.9%, vs 41.6%, 95% CI = 40.9% to 42.2%, in adults without a cancer history), and nearly one-quarter (22.9%, 95% CI = 21.6% to 24.3%) reported 2 or more, representing 8.7 million and 3.5 million cancer survivors, respectively. These conditions were more prevalent in survivors of kidney, liver, and uterine cancers as well as Black survivors and those with low socioeconomic status and public insurance. Findings highlight the need to protect survivors against COVID-19 transmission in health-care facilities and to prioritize cancer patients, survivors, caregivers, and their health-care providers in vaccine allocation.
AB - Cancer, and other underlying medical conditions including chronic obstructive pulmonary disease, heart diseases, diabetes, chronic kidney disease, and obesity, are associated with increased risk of severe coronavirus disease 2019 (COVID-19) illness. We identified 6411 cancer survivors and 77 748 adults without a cancer history from the 2016-2018 National Health Interview Survey and examined the prevalence and sociodemographic factors associated with these conditions in the United States. Most survivors reported having 1 or more of the conditions (56.4%, 95% confidence interval [CI] = 54.8% to 57.9%, vs 41.6%, 95% CI = 40.9% to 42.2%, in adults without a cancer history), and nearly one-quarter (22.9%, 95% CI = 21.6% to 24.3%) reported 2 or more, representing 8.7 million and 3.5 million cancer survivors, respectively. These conditions were more prevalent in survivors of kidney, liver, and uterine cancers as well as Black survivors and those with low socioeconomic status and public insurance. Findings highlight the need to protect survivors against COVID-19 transmission in health-care facilities and to prioritize cancer patients, survivors, caregivers, and their health-care providers in vaccine allocation.
UR - http://www.scopus.com/inward/record.url?scp=85110641265&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85110641265&partnerID=8YFLogxK
U2 - 10.1093/jnci/djab012
DO - 10.1093/jnci/djab012
M3 - Article
C2 - 33533404
AN - SCOPUS:85110641265
SN - 0027-8874
VL - 114
SP - 156
EP - 159
JO - Journal of the National Cancer Institute
JF - Journal of the National Cancer Institute
IS - 1
ER -